Heinz Sill

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 31

Top Venues

Leukemia

Blood

International journal of molecular sciences

Biomedicines

This page only lists publications with an associated author ORCID identifier.

Publications

Jennifer Moritz, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines 12 (3) (2024)
Jennifer Moritz, Antonia Schwab, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler
Measurable Residual Disease Detection in Acute Myeloid Leukemia: Current Challenges and Future Directions. Biomedicines 12 (3) (2024)
Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Karl Kashofer, Christine Beham-Schmid, Slave Trajanoski, Claudia Waskow, Wolfgang Schöll, Heinz Sill, Armin Zebisch, Albert Wölfler, Daniel Thomas, Andreas Reinisch
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia (2023)
Lisa Pleyer, Marc Vaisband, Manuel Drost, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Angelika Pichler, Bernd Hartmann, Andreas Petzer, Martin Schreder, Clemens A Schmitt, Sonia Vallet, Thomas Melchardt, Armin Zebisch, Petra Pichler, Nadja Zaborsky, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Jan Hasenauer, Julian Larcher-Senn, Richard Greil
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT. American journal of hematology (2023)
Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Karl Kashofer, Christine Beham-Schmid, Slave Trajanoski, Claudia Waskow, Wolfgang Schöll, Heinz Sill, Armin Zebisch, Albert Wölfler, Daniel Thomas, Andreas Reinisch
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia (2023)
Tommaso Sconocchia, Johannes Foßelteder, Lisa Auinger, Erdem Özkaya, Theresa Benezeder, Magdalena Lang, Christine Beham-Schmid, Gerald Hoefler, Armin Zebisch, Albert Wölfler, Heinz Sill, Peter Wolf, Herbert Strobl, Andreas Reinisch
BRAF V600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis. Leukemia (2023)
Michael Leisch, Michael Pfeilstöcker, Reinhard Stauder, Sonja Heibl, Heinz Sill, Michael Girschikofsky, Margarete Stampfl-Mattersberger, Christoph Tinchon, Bernd Hartmann, Andreas Petzer, Martin Schreder, David Kiesl, Sonia Vallet, Alexander Egle, Thomas Melchardt, Gudrun Piringer, Armin Zebisch, Sigrid Machherndl-Spandl, Dominik Wolf, Felix Keil, Manuel Drost, Richard Greil, Lisa Pleyer
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group. Cancers 14 (10) (2022)
Noemi Meszaros, Karin Lind, Robert Sehlke, Bojan Vilagos, Nikolaus Krall, Gregory I Vladimer, Heinz Sill
Influence of cryopreservation on drug responses and gene expression of AML cells: Implications for the use of biobanked tissues. British journal of haematology (2022)
Wei-Yu Lin, Sarah E Fordham, Eric Hungate, Nicola J Sunter, Claire Elstob, Yaobo Xu, Catherine Park, Anne Quante, Konstantin Strauch, Christian Gieger, Andrew Skol, Thahira Rahman, Lara Sucheston-Campbell, Junke Wang, Theresa Hahn, Alyssa I Clay-Gilmour, Gail L Jones, Helen J Marr, Graham H Jackson, Tobias Menne, Matthew Collin, Adam Ivey, Robert K Hills, Alan K Burnett, Nigel H Russell, Jude Fitzgibbon, Richard A Larson, Michelle M Le Beau, Wendy Stock, Olaf Heidenreich, Abrar Alharbi, David John Allsup, Richard S Houlston, Jean Norden, Anne M Dickinson, Elisabeth Douglas, Beverley Clare Lendrem, Ann K Daly, Louise Palm, Kim Piechocki, Sally Jeffries, Martin Bornhäuser, Christoph Röllig, Heidi Altmann, Leo Ruhnke, Desiree Kunadt, Lisa Wagenführ, Heather J Cordell, Rebecca Darlay, Mette K Andersen, Maria C Fontana, Giovanni Martinelli, Giovanni Marconi, Miguel Angel Sanz, José Cervera, Inés Gómez-Seguí, Thomas Cluzeau, Chimène Moreilhon, Sophie Raynaud, Heinz Sill, Maria Teresa Teresa Voso, Francesco Lo-Coco, Hervé Dombret, Meyling H Cheok, Claude Preudhomme, Rosemary E Gale, David Linch, Julia Gaal-Wesinger, Andras Masszi, Daniel Nowak, Wolf-Karsten Hofmann, Amanda Gilkes, Kimmo Porkka, Jelena D Milosevic Feenstra, Robert Kralovics, David Grimwade, Manja Meggendorfer, Torsten Haferlach, Szilvia Krizsán, Csaba Bödör, Friedrich Stölzel, Kenan Onel, James M Allan
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia. Nature communications 13 (1) (2022)
Armin Zebisch, Heinz Sill
How do non-coding RNAs impact treatment regimens currently being used in AML? Expert review of anticancer therapy 22 (4) (2022)
Sayantanee Dutta, Jennifer Moritz, Gudrun Pregartner, Gerhard G Thallinger, Ilona Brandstätter, Karin Lind, Simin Rezania, Freya Lyssy, Andreas Reinisch, Armin Zebisch, Andrea Berghold, Albert Wölfler, Heinz Sill
Comparison of acute myeloid leukemia and myelodysplastic syndromes with TP53 aberrations. Annals of hematology 101 (4) (2022)
Alexander Michael Grandits, Chi Huu Nguyen, Angela Schlerka, Hubert Hackl, Heinz Sill, Julia Etzler, Elizabeth Heyes, Dagmar Stoiber, Florian Grebien, Gerwin Heller, Rotraud Wieser
Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness. Leukemia 35 (10) (2021)
Wei-Yu Lin, Sarah E Fordham, Eric Hungate, Nicola J Sunter, Claire Elstob, Yaobo Xu, Catherine Park, Anne Quante, Konstantin Strauch, Christian Gieger, Andrew Skol, Thahira Rahman, Lara Sucheston-Campbell, Junke Wang, Theresa Hahn, Alyssa I Clay-Gilmour, Gail L Jones, Helen J Marr, Graham H Jackson, Tobias Menne, Matthew Collin, Adam Ivey, Robert K Hills, Alan K Burnett, Nigel H Russell, Jude Fitzgibbon, Richard A Larson, Michelle M Le Beau, Wendy Stock, Olaf Heidenreich, Abrar Alharbi, David John Allsup, Richard S Houlston, Jean Norden, Anne M Dickinson, Elisabeth Douglas, Beverley Clare Lendrem, Ann K Daly, Louise Palm, Kim Piechocki, Sally Jeffries, Martin Bornhäuser, Christoph Röllig, Heidi Altmann, Leo Ruhnke, Desiree Kunadt, Lisa Wagenführ, Heather J Cordell, Rebecca Darlay, Mette K Andersen, Maria C Fontana, Giovanni Martinelli, Giovanni Marconi, Miguel Angel Sanz, José Cervera, Inés Gómez-Seguí, Thomas Cluzeau, Chimène Moreilhon, Sophie Raynaud, Heinz Sill, Maria Teresa Teresa Voso, Francesco Lo-Coco, Hervé Dombret, Meyling H Cheok, Claude Preudhomme, Rosemary E Gale, David Linch, Julia Gaal-Wesinger, Andras Masszi, Daniel Nowak, Wolf-Karsten Hofmann, Amanda Gilkes, Kimmo Porkka, Jelena D Milosevic Feenstra, Robert Kralovics, David Grimwade, Manja Meggendorfer, Torsten Haferlach, Szilvia Krizsán, Csaba Bödör, Friedrich Stölzel, Kenan Onel, James M Allan
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia. Nature communications 12 (1) (2021)
Gregor Eisenwort, Irina Sadovnik, Alexandra Keller, Daniel Ivanov, Barbara Peter, Daniela Berger, Gabriele Stefanzl, Karin Bauer, Katharina Slavnitsch, Georg Greiner, Karoline V Gleixner, Wolfgang R Sperr, Michael Willmann, Heinz Sill, Peter Bettelheim, Klaus Geissler, Michael W Deininger, Thomas Rülicke, Peter Valent
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia. Leukemia 35 (11) (2021)
Johannes Lorenz Berg, Bianca Perfler, Stefan Hatzl, Barbara Uhl, Andreas Reinisch, Gudrun Pregartner, Andrea Berghold, Thomas Penz, Michael K Schuster, Klaus Geissler, Andreas Prokesch, Carsten Muller-Tidow, Gerald Hoefler, Karl Kashofer, Albert Wölfler, Heinz Sill, Veronica Caraffini, Armin Zebisch
EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity. Leukemia 35 (5) (2021)
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Elmir Graf, Thomas Nösslinger, Michael Pfeilstöcker, Heinz Tüchler, Thamer Sliwa, Felix Keil, Christoph Geissler, Sonja Heibl, Josef Thaler, Sigrid Machherndl-Spandl, Otto Zach, Ansgar Weltermann, Peter Bettelheim, Reinhard Stauder, Armin Zebisch, Heinz Sill, Ilse Schwarzinger, Bruno Schneeweiss, Leopold Öhler, Ernst Ulsperger, Rajko Kusec, Ulrich Germing, Wolfgang R Sperr, Paul Knöbl, Ulrich Jäger, Gregor Hörmann, Peter Valent
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients. International journal of molecular sciences 21 (8) (2020)
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Elmir Graf, Thomas Nösslinger, Michael Pfeilstöcker, Sigrid Machherndl-Spandl, Reinhard Stauder, Armin Zebisch, Heinz Sill, Leopold Öhler, Rajko Kusec, Gregor Hörmann, Peter Valent
Molecular Basis and Clinical Application of Growth-Factor-Independent In Vitro Myeloid Colony Formation in Chronic Myelomonocytic Leukemia. International journal of molecular sciences 21 (17) (2020)
Chi Huu Nguyen, Alexander Michael Grandits, Louise E Purton, Heinz Sill, Rotraud Wieser
All-trans retinoic acid in non-promyelocytic acute myeloid leukemia: driver lesion dependent effects on leukemic stem cells. Cell cycle (Georgetown, Tex.) 19 (20) (2020)
Gabriel Pabst, Karin Lind, Ricarda Graf, Armin Zebisch, Friedrich Stölzel, Konstanze Döhner, Ellen Heitzer, Andreas Reinisch, Heinz Sill
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model. Annals of hematology 99 (3) (2020)
Tina Moser, Julie Waldispuehl-Geigl, Jelena Belic, Sabrina Weber, Qing Zhou, Samantha O Perakis, Ricarda Graf, Jasmin Alia Terzic, Florian Posch, Heinz Sill, Sigurd F Lax, Karl Kashofer, Gerald Hoefler, Helmut Schoellnast, Ellen Heitzer, Jochen B Geigl, Thomas Bauernhofer, Michael R Speicher
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer. NPJ precision oncology 4 (1) (2020)
Subramanian Anirudh, Angelika Rosenberger, Elke Schwarzenberger, Carolin Schaefer, Herbert Strobl, Armin Zebisch, Heinz Sill, Albert Wölfler
TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPα. Cells 9 (5) (2020)
Sayantanee Dutta, Gudrun Pregartner, Frank G Rücker, Ellen Heitzer, Armin Zebisch, Lars Bullinger, Andrea Berghold, Konstanze Döhner, Heinz Sill
Functional Classification of TP53 Mutations in Acute Myeloid Leukemia. Cancers 12 (3) (2020)
Shruti Daga, Angelika Rosenberger, Karl Kashofer, Ellen Heitzer, Franz Quehenberger, Iris Halbwedl, Ricarda Graf, Nina Krisper, Barbara Prietl, Gerald Höfler, Andreas Reinisch, Armin Zebisch, Heinz Sill, Albert Wölfler
Sensitive and broadly applicable residual disease detection in acute myeloid leukemia using flow cytometry-based leukemic cell enrichment followed by mutational profiling. American journal of hematology (2020)
Heinz Sill, Armin Zebisch, Detlef Haase
Acute Myeloid Leukemia and Myelodysplastic Syndromes with TP53 Aberrations - A Distinct Stem Cell Disorder. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Armin Zebisch, Gerlinde Winter, Karl Kashofer, Stefan Hatzl, Barbara Uhl, Sonja Wurm, Albert Wölfler, Hildegard T Greinix, Gerald Hoefler, Heinz Sill
The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation. Bone marrow transplantation 55 (7) (2019)
Tobias Gluexam, Alexander M Grandits, Angela Schlerka, Chi Huu Nguyen, Julia Etzler, Thomas Finkes, Michael Fuchs, Christoph Scheid, Gerwin Heller, Hubert Hackl, Nathalie Harrer, Heinz Sill, Elisabeth Koller, Dagmar Stoiber, Wolfgang Sommergruber, Rotraud Wieser
CGRP Signaling via CALCRL Increases Chemotherapy Resistance and Stem Cell Properties in Acute Myeloid Leukemia. International journal of molecular sciences 20 (23) (2019)
Armin Zebisch, Veronica Caraffini, Heinz Sill
RAF Kinase Inhibitor Protein in Myeloid Leukemogenesis. International journal of molecular sciences 20 (22) (2019)
Veronica Caraffini, Bianca Perfler, Johannes Lorenz Berg, Barbara Uhl, Silvia Schauer, Karl Kashofer, Nassim Ghaffari-Tabrizi-Wizsy, Herbert Strobl, Albert Wölfler, Gerald Hoefler, Heinz Sill, Armin Zebisch
Loss of RKIP is a frequent event in myeloid sarcoma and promotes leukemic tissue infiltration. Blood 131 (7) (2018)
Kinkini N Magina, Gudrun Pregartner, Armin Zebisch, Albert Wölfler, Peter Neumeister, Hildegard T Greinix, Andrea Berghold, Heinz Sill
Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis. Blood 130 (7) (2017)
Ridhima Lal, Karin Lind, Ellen Heitzer, Peter Ulz, Kristina Aubell, Karl Kashofer, Jan M Middeke, Christian Thiede, Eduard Schulz, Angelika Rosenberger, Sybille Hofer, Birgit Feilhauer, Beate Rinner, Vendula Svendova, Michael G Schimek, Frank G Rücker, Gerald Hoefler, Konstanze Döhner, Armin Zebisch, Albert Wölfler, Heinz Sill
Somatic TP53 mutations characterize preleukemic stem cells in acute myeloid leukemia. Blood 129 (18) (2017)
Armin Zebisch, Ridhima Lal, Marian Müller, Karin Lind, Karl Kashofer, Michael Girschikofsky, David Fuchs, Albert Wölfler, Jochen B Geigl, Heinz Sill
Acute myeloid leukemia with TP53 germ line mutations. Blood 128 (18) (2016)

Heinz Sill.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Heinz Sill